Innovative independent Russia–based vaccine company, created by biotechnologists from NRC Institute of Immunology and I.I.Mechnikov Vaccine & Sera Institute
View full bio
Our team focuses on full cycle of vaccine development - from research to clinical trials – with product market introduction. We manufacture highly purified enteric vaccines, vaccine compounds, immunomodulators and conjugates with strongly defined characteristics. Our quality guarantee – complete physico-chemical characterization & validation of our products including modern methods (13C-NMR, ESI-MS etc.) which present direct “portrait” of product. Product manufacturing is performed in modern production facilities in agreement with cGMP, biohazard requirements.
- SHIGELLVAC – the first in the world vaccine against shigellosis, which confers effective protection against Shigella sonneiinfection. Development of strategy for vaccination against Shigella infections
- VAINVAC – the new generation vaccine against typhoid fever with fully chemically-defined structure (a capsular polysaccharide, Vi-antigen of Salmonella enterica sv typhi) and immunogenicity controlled properties.
Intravacc is an experienced R&D organization with a proven track record in vaccinology of over 100 years. We have a wide range of expertise to independently develop vaccines from lead concept to clinical phase I/II studies as wel as our own product pipeline and patents.